Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
08 Mai 2023 - 1:00PM
Business Wire
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a
biopharmaceutical company focused on discovering, developing, and
commercializing important new medicines to improve the lives of
people with cancer, today announced that members of the management
team will participate in a fireside chat at the JMP Securities Life
Sciences Conference on Monday, May 15, 2023 at 2:30 PM ET in New
York, NY.
A live webcast of the fireside chat will be available on the
“Events and Presentations” page in the “Investors” section of the
Company’s website at
https://investors.deciphera.com/events-presentations. A replay of
the webcast will be archived on the Company’s website for 90 days
following the presentation.
About Deciphera Pharmaceuticals
Deciphera is a biopharmaceutical company focused on discovering,
developing, and commercializing important new medicines to improve
the lives of people with cancer. We are leveraging our proprietary
switch-control kinase inhibitor platform and deep expertise in
kinase biology to develop a broad portfolio of innovative
medicines. In addition to advancing multiple product candidates
from our platform in clinical studies, QINLOCK® is Deciphera’s
switch-control inhibitor for the treatment of fourth-line GIST.
QINLOCK is approved in Australia, Canada, China, the European
Union, Hong Kong, Israel, Macau, New Zealand, Switzerland, Taiwan,
the United Kingdom, and the United States. For more information,
visit www.deciphera.com and follow us on LinkedIn and Twitter
(@Deciphera).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230508005047/en/
Investor Relations: Maghan Meyers Argot Partners
Deciphera@argotpartners.com 212-600-1902 Media: David Rosen
Argot Partners david.rosen@argotpartners.com 212-600-1902
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Deciphera Pharmaceuticals (NASDAQ:DCPH)
Historical Stock Chart
Von Mai 2023 bis Mai 2024